Stocktwits on MSN
Omeros stock jumps premarket after FDA approves first drug for rare transplant complication — retail sees big upside
The FDA approval clears the path for a U.S. launch in January 2026. ・Trial and expanded access data showed strong response ...
Lower-income countries rarely gain timely access to FDA-approved drugs tested in their populations, highlighting major global and ethical disparities. Physical access was defined as where a tested ...
Missouri, Kansas and Idaho have renewed their efforts to restrict access to the abortion drug mifepristone, filing a joint amended lawsuit against the Food and Drug Administration (FDA). The lawsuit ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results